Do we need still more trials on T4 and T3 combination therapy in hypothyroidism?

European Journal of Endocrinology

Volumn 161, Issue 6, 2009, Pages 955-959

  Wiersinga, Wilmar M ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

LIOTHYRONINE; THYROID HORMONE; THYROTROPIN; THYROXINE; THYROXINE DEIODINASE;

CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DEPRESSION; DRUG FORMULATION; EVENING DOSAGE; FATIGUE; GENETIC POLYMORPHISM; HUMAN; HYPOTHYROIDISM; MONOTHERAPY; NOTE; PRIORITY JOURNAL; WELLBEING;

CROSS-OVER STUDIES; DRUG THERAPY, COMBINATION; HUMANS; HYPOTHYROIDISM; IODIDE PEROXIDASE; PATIENT SATISFACTION; POLYMORPHISM, GENETIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; THYROTROPIN; THYROXINE; TRIIODOTHYRONINE;

EID: 72949123467     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-09-0879     Document Type: Note

References (35)

1. Grozinsky-Glasberg S, Fraser A, Nahshoni E, Weizman A & Leibovici L. Thyroxine - triiodothyronine combination therapy versus thyroxine monotherapy for clinical hypothyroidism: meta-analysis of randomized controlled trials. Journal of Clinical Endocrinology and Metabolism 2006 91 2592-2599.
2. 4 monotherapy in patients with hypothyroidism, a double-blind, randomized cross-over study. European Journal of Endocrinology, 2009.
3. Wekking EM, Appelhof BC, Fliers E, Schene AH, Huyser J, Tijssen JGP & Wiersinga WM. Cognitive functioning and well-being in euthyroid patients on thyroxine replacement therapy for primary hypothyroidism. European Journal of Endocrinology 2005 153 747-753.
4. Saravanan P, Chau WF, Roberts N, Vedhara K, Greenwood R & Dayan CM. Psychological well-being in patients on 'adequate' doses of L-thyroxine: results of a large, controlled communitybased questionnaire study. Clinical Endocrinology 2002 57 577-585.
5. Bunevicius R, Kazanavicius G, Zalinkevicius R & Prange AJ Jr. Effects of thyroxine as compared with thyroxine plus triiodothyronine in patients with hypothyroidism. New England Journal of Medicine 1999 340 424-429.
6. Bunevicius R, Jakubonien N, Jurkevicius R, Cernicat J, Lasas L & Prange AJ Jr. Thyroxine vs thyroxine plus triiodothyronine in treatment of hypothyroidism after thyroidectomy for Graves' disease. Endocrine 2002 18 129-133.
7. Walsh JP, Shiels L, Lim EM, Bhagat CI, Ward LC, Stuckey BG, Dhaliwal SS, Chew GT, Bhagat MC & Cussons AJ. Combined thyroxine/liothyronine treatment does not improve well-being, quality of life, or cognitive function compared to thyroxine alone: a randomized controlled trial in patients with primary hypothyroidism. Journal of Clinical Endocrinology and Metabolism 2003 88 4543-4550.
8. 4 alone in patients with hypothyroidism? Results of a double-blind, randomized, controlled trial. Journal of Clinical Endocrinology and Metabolism 2003 88 4551-4555.
9. Clyde PW, Harari AE, Getka EJ & Shakir KM. Combined levothyroxine plus liothyronine compared with levothyroxine alone in primary hypothyroidism: a randomized controlled trial. Journal of the American Medical Association 2003 290 2952-2958.
10. Siegmund W, Spieker K, Weike AI, Giessmann T, Modess C, Dabers T, Kirsche G, Sänger E, Engel G, Hamm AO, Nauck M & Meng W. Replacement therapy with levothyroxine plus triiodothyronine (bioavailable molar ratio 14:1) is not superior to thyroxine alone to improve well-being and cognitive performance in hypothyroidism. Clinical Endocrinology 2004 60 750-757.
11. 4 replacement therapy: results of a large community-based randomized controlled trial. Journal of Clinical Endocrinology and Metabolism 2005 90 805-812.
12. Rodriguez T, Lavis VR, Meininger JC, Kapadia AS & Stafford LF. Substitution of liothyronine at a 1:5 ratio for a portion of levothyroxine: effect on fatigue, symptoms of depression, and working memory versus treatment with levothyroxine alone. Endocrine Practice 2005 11 223-233.
13. Escobar-Morreale HF, Botella-Carretero JI, Gomez-Bueno M, Galan JM, Barrios V & Sancho J. Thyroid hormone replacement therapy in primary hypothyroidism: a randomized trial comparing L-thyroxine plus liothyronine with L-thyroxine alone. Annals of Internal Medicine 2005 142 412-424.
14. Appelhof BC, Fliers E, Wekking EM, Schene AH, Huyser J, Tijssen JG, Endert E, van Weert HCPM & Wiersinga WM. Combined therapy with levothyroxine and liothyronine in two ratios, compared with levothyroxine monotherapy in primary hypothyroidism: a double-blind, randomized, controlled clinical trial. Journal of Clinical Endocrinology and Metabolism 2005 90 2666-2674.
15. 4. Proceedings of the 74th Annual Meeting of the American Thyroid Association, Los Angeles, CA, USA, 2002.
16. Bianco AC, Salvatore D, Gereben B, Berry MJ & Larsen PR. Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocrine Reviews 2002 23 38-39.
17. Fish LH, Schwartz HJ, Cavanaugh J, Steffes MW, Bantle JP & Oppenheimer JH. Replacement dose, metabolism and bioavailability of levothyroxine in the treatment of hypothyroidism. New England Journal of Medicine 1987 316 764-770.
18. Escobar-Morreale HF, Botella-Carretero JI, Escobar del Rey F & Morreale de Escobar G. Review: treatment of hypothyroidism with combinations of levothyroxine plus liothyronine. Journal of Clinical Endocrinology and Metabolism 2005 90 4946-4954.
19. Jonklaas J, Davidson B, Bhagat S & Soldin SJ. Triiodothyronine levels in athyreotic individuals during levothyroxine therapy. Journal of the American Medical Association 2008 299 769-777.
20. 3 in normal subjects: a clue to the understanding of subclinical thyroid disease. Journal of Clinical Endocrinology and Metabolism 2002 87 1068-1072.
21. Walsh JP, Ward LC, Burke V, Bhagat CI, Shiels L, Healey D, Gillett MJ, Gilbert R, Tanner M & Stuckey GA. Small changes in thyroxine dosage do not produce measurable changes in hypothyroid symptoms, well-being, or quality of life: results of a double-blind, randomized clinical trial. Journal of Clinical Endocrinology and Metabolism 2006 91 2624-2630.
22. 4 therapy. Experimental and Clinical Endocrinology and Diabetes 2007 115 261-267.
23. Henneman G, Docter R, Visser TJ, Postema PT & Krenning EP. Thyroxine plus low-dose, slow-release triiodothyronine replacement in hypothyroidism. Thyroid 2004 14 271-275.
24. RussellW, Harrison RF, Smith N, Darzy K, Shalet S,Weetman AP & Ross RJ. Free triiodothyronine has a distinct circadian rhythm that is delayed but parallels thyrotropin levels. Journal of Clinical Endocrinology and Metabolism 2008 93 2300-2306.
25. Dayan CM & Panicker V. Novel insights into thyroid hormones from the study of common genetic variation. Nature Reviews. Endocrinology 2009 5 211-218.
26. van der Deure WM, Hansen PS, Peeters RP, Uitterlinden AG, Fenger M, Kyvik KO, Hegedus L & Visser TJ. The effect of genetic variation in the type 1 deiodinase gene on the interindividual variation in serum thyroid hormone levels: an investigation in healthy Danish twins. Clinical Endocrinology 2009 70 954-960.
27. Panicker V, Cluett C, Shields B, Murray A, Parnell KS, Perry JRB, Weedon MN, Singleton A, Hernandez D, Evans J, Durant C, Ferruci L, Melzer D, Saranavan P, Visser TJ, Ceresini G, Hattersley AT, Vaidya B, Dayan CM & Frayling TM. A common variation in deiodinase 1 gene DIO1 is associated with the relative levels of free thyroxine and triiodothyronine. Journal of Clinical Endocrinology and Metabolism 2008 93 3075-3080.
28. 1-triiodothyronine levels in patients on thyroid hormone replacement. Journal of Clinical Endocrinology and Metabolism 2006 91 3389-3393.
29. Panicker V, Saranavan P, Vaidya B, Evans J, Hattersley AT, Frayling TM & Dayan CM. Common variation in the DIO2 gene predicts baseline psychological well-being and response to combination thyroxine plus triiothyronine therapy in hypothyroid patients. Journal of Clinical Endocrinology and Metabolism 2009 94 1623-1629.
30. Jan de Jong F, Peeters RP, den Heijer T, van der Deure WM, Hofman A, Uitterlinden AG, Visser TJ & Breteler MMB. The association of polymorphisms in the type 1 and 2 deiodinase genes with circulating thyroid hormone parameters and atrophy of the medial temporal lobe. Journal of Clinical Endocrinology and Metabolism 2007 92 636-640.
31. Heemstra KA, Hoftijzer HC, van der Deure WM, Peeters RP, Fliers E, Appelhof BC, Wiersinga WM, Corssmit EPM, Visser TJ & Smit JWA. The 92 Ala polymorphism in the type 2 deiodinase is not associated with T4 dose in athyroid patients or patients with Hashimoto thyroiditis. Clinical Endocrinology 2009 71 279-283.
32. 1-triiodothyronine therapy. Journal of Clinical Endocrinology and Metabolism 2005 90 6296-6299.
33. van der Deure WM, Appelhof BC, Peeters RP, Wiersinga WM, Wekking EM, Huyser J, Schene AH, Tijssen JGP, Hoogendijk WJG, Visser TJ & Fliers E. Polymorphism in the brain-specific thyroid hormone transporter OATP-C1 are associated with fatigue and depression in hypothyroid patients. Clinical Endocrinology 2008 69 804-811.
34. Kim BW & Bianco AC. For some, L-thyroxine replacement might not be enough: a genetic rationale. Journal of Clinical Endocrinology and Metabolism 2009 94 1521-1523.
35. Kaplan MM, Sarne DH & Schneider AB. In search of the impossible dream? Thyroid hormone replacement that treats all symptoms in all hypothyroid patients. Journal of Clinical Endocrinology and Metabolism 2003 88 4540-4542.